RISS STAGE I PLASMA CELL MYELOMA
Clinical trials for RISS STAGE I PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE I PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE I PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for myeloma: 4-Drug cocktail tested in major trial
Disease control Recruiting nowThis study tests whether adding a fourth drug (bortezomib) to a standard three-drug regimen (daratumumab, lenalidomide, dexamethasone) helps people with newly diagnosed multiple myeloma live longer or keep cancer from coming back. About 1,450 adults who are not eligible for early…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Blood samples from 2000 people could unlock early cancer detection
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people, some with cancer and some without, to create a reference set for evaluating blood tests that aim to detect multiple cancers early. The goal is to help researchers develop and validate these tests so they can find canc…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC